Is caplyta a controlled substance?

Is Caplyta (lumateperone) considered a controlled substance?

Caplyta (lumateperone) is not listed as a controlled substance. No controlled-substance scheduling applies to lumateperone.

How to check quickly (and why it matters)

In the U.S., controlled-substance status is determined by DEA scheduling. If a medication is controlled, it typically appears in the DEA schedule information associated with the drug and is also reflected in how pharmacies handle prescribing and refills. Caplyta is not generally subject to those restrictions because it is not scheduled.

Does Caplyta carry addiction or misuse risk like opioids or benzodiazepines?

Caplyta is an antipsychotic used for schizophrenia and depressive symptoms in bipolar I or bipolar depression. It does not function as a benzodiazepine, opioid, or other classic high-abuse-risk category, and it is not treated as a scheduled drug.

What about insurance, refills, or pharmacy limits?

Even though Caplyta is not controlled, pharmacies still follow standard rules for prescription verification, refill limits, and state regulations on dispensing. Those are separate from DEA controlled-substance scheduling.

Sources

No provided sources.